kt-333
T-Cell Prolymphocytic Leukemia
Explore 9 assets in T-Cell Prolymphocytic Leukemia →Kymera Therapeutics, Inc.UNKNOWNPhase 1
—
Rating in progress
kt-333 in T-Cell Prolymphocytic Leukemia is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active